Skip to main content

HCC-TACE-SEG

The Cancer Imaging Archive

HCC-TACE-Seg | Multimodality annotated HCC cases with and without advanced imaging segmentation

DOI: 10.7937/TCIA.5FNA-0924 | Data Citation Required | 1.3k Views | 6 Citations | Image Collection

Location Species Subjects Data Types Cancer Types Size Supporting Data Status Updated
Liver Human 105 SEG, CT, Follow-Up, Molecular Test, Demographic, Exposure, Measurement, Treatment, Classification Hepatocellular carcinoma 28.57GB Clinical, Image Analyses, Software/Source Code Public, Complete 2022/08/17

Summary

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with incidences doubled over the past two decades due to increasing risk factors. Despite surveillance, the majority of HCC cases are diagnosed at advanced stages that can be treated only using (Transarterial chemoembolization) TACE, or systemic therapy. TACE failure can occur to 60% of patients receiving the procedure, with subsequent financial and emotional burden. Radiomics have emerged as a new tool capable of predicting tumor response to TACE from pre-procedural CT study.

This retrospectively acquired data collection includes pre- and post-procedure CT imaging studies of 105 confirmed HCC patients who underwent TACE between 2002 and 2012 with an available treatment outcome, in the form of time-to-progression and overall survival. Baseline imaging includes multiphasic contrast-enhanced CT with no image artifacts (e.g. surgical clip) and was obtained 1-12 weeks (average 3 weeks) prior to the first TACE session. Semiautomatic segmentation of liver, tumor, and blood vessels created using AMIRA was manually clinically curated. These segmentations of each pre-procedural CT study were done for the purpose of algorithm training for prediction and automatic liver tumor segmentation, and are provided here (NIfTI converted to DICOM-SEG format).

Data Access

Version 1: Updated 2022/08/17

Title Data Type Format Access Points Subjects Studies Series Images License
Images and Segmentations SEG, CT DICOM
Download requires NBIA Data Retriever
105 211 677 51,968 CC BY 4.0
Clinical data with description Follow-Up, Molecular Test, Demographic, Exposure, Measurement, Treatment, Classification XLSX CC BY 4.0
Related Datasets
No related Analysis Results found: Submit your proposal! No related Collections found
Legend: Analysis Results| Collections

Additional Resources for this Dataset

The following external resources have been made available by the data submitters.  These are not hosted or supported by TCIA, but may be useful to researchers utilizing this collection.

The NCI Cancer Research Data Commons (CRDC) provides access to additional data and a cloud-based data science infrastructure that connects data sets with analytics tools to allow users to share, integrate, analyze, and visualize cancer research data.

Citations & Data Usage Policy

Data Citation Required: Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution must include the following citation, including the Digital Object Identifier:

Data Citation

Moawad, A. W., Fuentes, D., Morshid, A., Khalaf, A. M., Elmohr, M. M., Abusaif, A., Hazle, J. D., Kaseb, A. O., Hassan, M., Mahvash, A., Szklaruk, J., Qayyom, A., & Elsayes, K. (2021). Multimodality annotated HCC cases with and without advanced imaging segmentation [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/TCIA.5FNA-0924

Detailed Description

These SEG were originally created as NIfTI format files (Amira Software, ThermoFisher 2019) , and converted to DICOM.

Github link for the NN code: https://github.com/fuentesdt/livermask

Note – the mask on Patient ID HCC_001 (SEG file Series UID 1.2.276.0.7230010.3.1.3.8323329.719.1600928570.399942) has a slightly different dimension than the CT (Series UI 1.3.6.1.4.1.14519.5.2.1.1706.8374.302065206690360709343725942120) . This difference is is far from the interesting features and the masks, so clinical interpretation should be unaffected by this discrepancy.

Acknowledgements

We would like to acknowledge the individuals and institutions that have provided data for this collection:

  • The University of Texas MD Anderson Cancer Center, Departments of Imaging Physics, Body Imaging, Gastrointestinal Oncology, Epidemiology, and Interventional Radiology.

  • Harmonization of the components of this dataset, including into standard DICOM representation, was supported in part by the NCI Imaging Data Commons consortium. NCI Imaging Data Commons consortium is supported by the contract number 19X037Q from Leidos Biomedical Research under Task Order HHSN26100071 from NCI.

Related Publications

Publications by the Dataset Authors

The authors recommended the following as the best source of additional information about this dataset:

Publication Citation

Morshid, A., Elsayes, K. M., Khalaf, A. M., Elmohr, M. M., Yu, J., Kaseb, A. O., Hassan, M., Mahvash, A., Wang, Z., Hazle, J. D., & Fuentes, D. (2019). A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization. Radiology: Artificial Intelligence, 1(5), e180021. https://doi.org/10.1148/ryai.2019180021 

No other publications were recommended by dataset authors.

Publication Citation

Morshid, A., Elsayes, K. M., Khalaf, A. M., Elmohr, M. M., Yu, J., Kaseb, A. O., Hassan, M., Mahvash, A., Wang, Z., Hazle, J. D., & Fuentes, D. (2019). A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization. Radiology: Artificial Intelligence, 1(5), e180021. https://doi.org/10.1148/ryai.2019180021 

Research Community Publications

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you’d like to add please contact the TCIA Helpdesk.

  1. Moawad, A. W., Morshid, A., Khalaf, A. M., Elmohr, M. M., Hazle, J. D., Fuentes, D., Badawy, M., Kaseb, A. O., Hassan, M., Mahvash, A., Szklaruk, J., Qayyum, A., Abusaif, A., Bennett, W. C., Nolan, T. S., Camp, B., & Elsayes, K. M. (2023). Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation. In Scientific Data (Vol. 10, Issue 1).  https://doi.org/10.1038/s41597-023-01928-3

TCIA maintains a list of publications that leveraged this dataset. If you have a manuscript you’d like to add please contact TCIA’s Helpdesk.

Other Publications Using this Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you’d like to add please contact the TCIA Helpdesk.

  1. Moawad, A. W., Morshid, A., Khalaf, A. M., Elmohr, M. M., Hazle, J. D., Fuentes, D., Badawy, M., Kaseb, A. O., Hassan, M., Mahvash, A., Szklaruk, J., Qayyum, A., Abusaif, A., Bennett, W. C., Nolan, T. S., Camp, B., & Elsayes, K. M. (2023). Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation. In Scientific Data (Vol. 10, Issue 1).  https://doi.org/10.1038/s41597-023-01928-3